|
by Melnikow, Joy
Published 2018
Subjects:
“...United States...”Published 2018
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Helfand, Mark, Mahon, Susan, Eden, Karen B.
Published 2001
Subjects:
“...United States...”Published 2001
Agency for Healthcare Research and Quality (US)
|
by Hartmann, Katherine E., Hall, Susan A., Nanda, Kavita, Boggess, John F.
Published 2002
Subjects:
“...United States...”Published 2002
Agency for Healthcare Research and Quality (US)
|
by Henderson, Jillian T., Webber, Elizabeth M., Vesco, Kimberly K., Thomas, Rachel G.
Published 2023
“... Services Task Force in updating its recommendation on Preeclampsia Screening. The review aim was to compare...”Published 2023
Agency for Healthcare Research and Quality
|
by Chou, Roger
Published 2019
“... interval (CI), 0.33 to 0.66; I2=67%; absolute risk reduction, −2.0% [95% CI, −2.8% to −1.2%] after 4 months...”Published 2019
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Chou, Roger
Published 2019
“... interval (CI), 0.33 to 0.66; I2=67%; absolute risk reduction, −2.0% [95% CI, −2.8% to −1.2%] after 4 months...”Published 2019
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Melnikow, Joy
Published 2018
“...Data to compare potential harms of different screening strategies were similarly limited, and none...”Published 2018
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Helfand, Mark, Mahon, Susan, Eden, Karen B.
Published 2001
“... who are seeing a physician for other reasons, is the most promising strategy for addressing the excess...”Published 2001
Agency for Healthcare Research and Quality (US)
|
by Hartmann, Katherine E., Hall, Susan A., Nanda, Kavita, Boggess, John F.
Published 2002
Published 2002
Agency for Healthcare Research and Quality (US)